Bayer’s Monsanto proposes $7.25B settlement to resolve decades of Roundup cancer lawsuits

In a strategic move to contain one of the most litigious chapters in corporate history, Bayer’s subsidiary, Monsanto, announced a proposed $7.25 billion nationwide class-action settlement on Tuesday — aiming to resolve the vast majority of current and future claims related to its Roundup weedkiller causing non-Hodgkin lymphoma (NHL).